Is vaccine the magic bullet for malaria elimination? A reality check

by Chilengi Roma, Gitaka Jesse
Published 2010-12-01

Cohort study of the association of antibody levels to AMA1, MSP1₁₉, MSP3 and GLURP with protection from clinical malaria in Ghanaian children

by Bosomprah Samuel, Milligan Paul, Remarque Ed, Lamptey Helena, Kusi Kwadwo, Aikins Anastasia, Dodoo Daniel, Chilengi Roma, Osei Yaa Difie, Akanmori Bartholomew, Theisen Michael
Published 2008-07-01

Safety and efficacy of lumefantrine-artemether (Coartem^®) for the treatment of uncomplicated <it>Plasmodium falciparum </it>malaria in Zambian adults

by Mulenga Modest, Van geertruyden Jean-Pierre, Mwananyanda Lawrence, Chalwe Victor, Moerman Filip, Chilengi Roma, Van Overmeir Chantal, Dujardin Jean-Claude, D'Alessandro Umberto
Published 2006-08-01

Engaging diverse communities participating in clinical trials: case examples from across Africa

by Doumbo Ogobara, Tiono Alfred B, Lusingu John, Sissoko Mahamadou S, Thera Mahamadou A, Mtenga Sally, Ishengoma Deus, Chilengi Roma, Nyika Aceme, Sirima Sodiomon B, Lemnge Martha, Kilama Wen L
Published 2010-03-01

Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12–24 months

by Segeja Method D, Minja Daniel, Rutta Acleus, Sembuche Samwel, Seth Misago, Lemnge Martha, Francis Filbert, Msham Salum, Gesase Samwel, Lusingu John PA, Bosomprah Samuel, Cousens Simon, Noor Ramadhani, Chilengi Roma, Druilhe Pierre
Published 2009-07-01

A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers

by Oyoo George O, Kipkeu Chemtai, Jemutai Julie, Wenwa Ednah, Mwambingu Gabriel, Salim Amina, Anabwani Evelyn, Nyakundi Priscilla, Lodenyo Hudson, Bashraheil Mahfudh, Abdallah Ahmed M, Juma Rashid, Chilengi Roma, Muchohi Simon N, Kokwaro Gilbert, Niehues Tim, Lang Trudie, Nzila Alexis
Published 2011-03-01

Correction: Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children

by Sodiomon B. Sirima, Alfred B. Tiono, Alphonse Ouédraogo, Amidou Diarra, André Lin Ouédraogo, Jean Baptiste Yaro, Espérance Ouédraogo, Adama Gansané, Edith C. Bougouma, Amadou T. Konaté, Youssouf Kaboré, Abdoulaye Traoré, Chilengi Roma, Issiaka Soulama, Adrian J. F. Luty, Pierre Druilhe, Simon Cousens, Issa Nébié
Published 2010-01-01

Correction: Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children.

by Sodiomon B. Sirima, Alfred B. Tiono, Alphonse Ouédraogo, Amidou Diarra, André Lin Ouédraogo, Jean Baptiste Yaro, Espérance Ouédraogo, Adama Gansané, Edith C. Bougouma, Amadou T. Konaté, Youssouf Kaboré, Abdoulaye Traoré, Chilengi Roma, Issiaka Soulama, Adrian J. F. Luty, Pierre Druilhe, Simon Cousens, Issa Nébié
Published 2010-01-01